Ponatinib is a BCR-ABL inhibitor. It’s used for treating Chronic Myeloid Leukemia, Ph-positive Acute Lymphoblastic Leukemia, especially when previous treatments haven’t worked. It hits on a bunch of different kinase things.
You got two options, the 15 mg and the 45 mg tablets, which both have a film coating. The usual dose is 45 mg a day, you can take it with or without food. These tablets come in bottles with a stack of 30.
